EK

Efrem Kamen

North America, New York, United States, New York

Description

Efrem Kamen is the Adjunct Professor at Columbia Business School. Efrem Kamen attended Columbia University in the City of New York.

Investor Profile

Efrem Kamen has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (50%)
  • Convertible Note (50%)

Country Focus

  • Germany (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Mental Health
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Efrem Kamen frequently co-invest with?

Thiel Capital
North America, California, United States, Los Angeles
Co-Investments: 1
Infinitas Capital
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Bracket Capital
North America, California, United States, West Hollywood
Co-Investments: 1
What If Ventures
North America, Texas, United States, Frisco
Co-Investments: 1
Subversive Capital
North America, New York, United States, New York
Co-Investments: 1
BC
North America, California, United States, Santa Monica
Co-Investments: 1
MC
Europe, Kyyiv, Ukraine, Kyiv
Co-Investments: 1
Able Partners
North America, New York, United States, New York
Co-Investments: 1
Recharge Capital
North America, New York, United States, New York
Co-Investments: 1
Apeiron Investment Group
Europe, NA - Malta, Malta, Sliema
Co-Investments: 1

Which angels does Efrem Kamen often collaborate with?

TB
Europe, England, United Kingdom, London
Shared Deals: 1
SJ
North America, California, United States, San Francisco
Shared Deals: 1
PT
North America, California, United States, San Francisco
Shared Deals: 1
MM
North America, California, United States, San Francisco
Shared Deals: 1
MN
North America, New York, United States, New York
Shared Deals: 1
CA
Europe, England, United Kingdom, London
Shared Deals: 1
MS
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Efrem Kamen?

ATAI Life Sciences

Munich, Bayern, Germany

ATAI Life Sciences develops innovative mental health treatments that address significant unmet medical needs.

BiotechnologyHealth CareLife ScienceMental HealthTherapeutics
Convertible NoteApr 27, 2020
Amount Raised: $25,000,000
ATAI Life Sciences

Munich, Bayern, Germany

ATAI Life Sciences develops innovative mental health treatments that address significant unmet medical needs.

BiotechnologyHealth CareLife ScienceMental HealthTherapeutics
Series BMar 1, 2019
Amount Raised: $43,000,000